Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 2 3Phase EARLY_PHASE1 1

Status

Recruiting 4Terminated 2Completed 2Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 3Sarcoma 1Dermatologic 1

Conditions

Oligodendroglioma 1Neurocytoma 1Neoplasms, Neuroepithelial 1NF1 1Liposarcoma, Myxoid 1Liposarcoma 1Glioma 1Ganglioneuroma 1Ganglioglioma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

pembrolizumab 109Cyclophosphamide 89fludarabine 70Carboplatin 57Injections 56Bevacizumab 49Specimen Handling 43Gemcitabine 41Magnetic Resonance Spectroscopy 40Paclitaxel 39Nivolumab 38venetoclax 36Dexamethasone 35Cisplatin 34Biopsy 34Temozolomide 31Docetaxel 29atezolizumab 27Capecitabine 27Oxaliplatin 26Fluorouracil 26Pemetrexed 24Irinotecan 24Azacitidine 24abemaciclib 23toripalimab 22Fulvestrant 22fludarabine phosphate 21Rituximab 21Leucovorin 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Recruiting × mirdametinib × Clear all
NCT06843967 2026-05-22

A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting
54 enrolled
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT07539441 2026-05-13

A Study of Mirdametinib in People With Central Nervous System Tumors

Memorial Sloan Kettering Cancer Center

Phase 1/2 Recruiting
26 enrolled
CNS

Glioma, Central Nervous System Neoplasms

NCT06159166 2026-04-13

Mirda

Johns Hopkins University

Phase 1/2 Recruiting
24 enrolled
CNSDermatologic

NF1

NCT04923126 2026-02-04

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
132 enrolled
CNS

Astrocytoma, Ganglioneuroma, Oligodendroglioma, Neoplasms, Neuroepithelial, Ganglioglioma, Neurocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡